Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 263

1.

Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine.

Knoepfler PS.

Stem Cells. 2009 May;27(5):1050-6. doi: 10.1002/stem.37. Review.

2.

The tumorigenicity of human embryonic stem cells.

Blum B, Benvenisty N.

Adv Cancer Res. 2008;100:133-58. doi: 10.1016/S0065-230X(08)00005-5. Review.

PMID:
18620095
3.

Sources of stem cells for regenerative medicine.

Hipp J, Atala A.

Stem Cell Rev. 2008 Spring;4(1):3-11. doi: 10.1007/s12015-008-9010-8. Review.

PMID:
18286392
4.

Therapeutic potential of embryonic stem cells.

Lerou PH, Daley GQ.

Blood Rev. 2005 Nov;19(6):321-31. Review.

PMID:
16275420
5.

Pluripotent stem cells.

Verfaillie C.

Transfus Clin Biol. 2009 May;16(2):65-9. doi: 10.1016/j.tracli.2009.04.006. Epub 2009 May 12. Review.

PMID:
19442552
6.

Is teratoma formation in stem cell research a characterization tool or a window to developmental biology?

Aleckovic M, Simón C.

Reprod Biomed Online. 2008 Aug;17(2):270-80. Review.

PMID:
18682004
7.

Induced pluripotent stem cells: current progress and potential for regenerative medicine.

Amabile G, Meissner A.

Trends Mol Med. 2009 Feb;15(2):59-68. doi: 10.1016/j.molmed.2008.12.003. Epub 2009 Jan 21. Review.

PMID:
19162546
8.

Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery.

Braam SR, Passier R, Mummery CL.

Trends Pharmacol Sci. 2009 Oct;30(10):536-45. doi: 10.1016/j.tips.2009.07.001. Epub 2009 Sep 15. Review.

PMID:
19762090
9.

Regenerative medicine: a 2009 overview.

Andersson ER, Lendahl U.

J Intern Med. 2009 Oct;266(4):303-10. doi: 10.1111/j.1365-2796.2009.02157.x.

10.

New and renewed perspectives on embryonic stem cell pluripotency.

Hoffman JA, Merrill BJ.

Front Biosci. 2007 May 1;12:3321-32. Review.

PMID:
17485302
11.

Are induced pluripotent stem cells the future of cell-based regenerative therapies for spinal cord injury?

Salewski RP, Eftekharpour E, Fehlings MG.

J Cell Physiol. 2010 Mar;222(3):515-21. doi: 10.1002/jcp.21995. Review.

PMID:
20020443
12.

Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming.

Li W, Ding S.

Trends Pharmacol Sci. 2010 Jan;31(1):36-45. doi: 10.1016/j.tips.2009.10.002. Epub 2009 Nov 4. Review.

PMID:
19896224
13.

Exploiting pluripotency for therapeutic gain.

Deng W.

Panminerva Med. 2010 Jun;52(2):167-73. Review.

PMID:
20517198
14.

Embryonic stem cells and prospects for their use in regenerative medicine approaches to motor neurone disease.

Christou YA, Moore HD, Shaw PJ, Monk PN.

Neuropathol Appl Neurobiol. 2007 Oct;33(5):485-98. Review.

PMID:
17854436
15.

The promise of stem cell research in pigs and other ungulate species.

Telugu BP, Ezashi T, Roberts RM.

Stem Cell Rev. 2010 Mar;6(1):31-41. doi: 10.1007/s12015-009-9101-1. Review.

PMID:
19949895
16.

Induced pluripotent stem (iPS) cells as in vitro models of human neurogenetic disorders.

Chamberlain SJ, Li XJ, Lalande M.

Neurogenetics. 2008 Oct;9(4):227-35. doi: 10.1007/s10048-008-0147-z. Epub 2008 Sep 13. Review.

PMID:
18791750
17.

Very small embryonic-like stem cells for regenerative medicine: WO2010039241.

Taupin P.

Expert Opin Ther Pat. 2010 Aug;20(8):1103-6. doi: 10.1517/13543776.2010.495122.

PMID:
20518618
18.
19.

Stretching the limits: stem cells in regeneration science.

Stocum DL, Zupanc GK.

Dev Dyn. 2008 Dec;237(12):3648-71. doi: 10.1002/dvdy.21774. Review.

20.

[Human embryonic stem cells: clinical potential and current challenges].

Oliveri RS, Andersen CY.

Ugeskr Laeger. 2008 May 19;170(21):1815-20. Review. Danish.

PMID:
18492447

Supplemental Content

Support Center